Managing Locally Advanced Head and Neck Cancer
Author Information
Author(s): Seiwert T Y, Cohen E E W
Primary Institution: The University of Chicago
Conclusion
Treatment for locally advanced head and neck squamous cell carcinoma has improved dramatically, allowing for better survival rates and organ preservation.
Supporting Evidence
- Adjuvant chemoradiotherapy has been shown to improve survival rates in patients with high-risk features.
- Concomitant chemoradiotherapy has become a standard treatment for locally advanced head and neck cancer.
- EGFR inhibitors may enhance treatment efficacy and reduce toxicity.
Takeaway
Doctors have found better ways to treat a type of throat cancer, helping more people live longer and keep their important body parts.
Methodology
The article reviews various treatment approaches for locally advanced head and neck squamous cell carcinoma, including surgery, chemoradiotherapy, and the use of epidermal growth factor receptor inhibitors.
Potential Biases
Potential biases in patient selection and treatment protocols may affect the interpretation of results.
Limitations
The evidence for some treatment approaches is based on lower-level studies, and there is a lack of randomized trials for certain comparisons.
Participant Demographics
The article discusses treatment for patients with locally advanced head and neck squamous cell carcinoma, but specific demographics are not provided.
Statistical Information
P-Value
P<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website